Multidrug-Resistant Urinary Tract Isolates of Escherichia coli: Prevalence and Patient Demographics in the United States in 2000
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Concurrent resistance to antimicrobials of different structural classes has arisen in a multitude of bacterial species and may complicate the therapeutic management of infections, including those of the urinary tract. To assess the current breadth of multidrug resistance among urinary isolates of Escherichia coli, the most prevalent pathogen contributing to these infections, all pertinent results in The Surveillance Network Database—USA from 1 January to 30 September 2000 were analyzed. Results were available for 38,835 urinary isolates of E. coli that had been tested against ampicillin, cephalothin, ciprofloxacin, nitrofurantoin, and trimethoprim-sulfamethoxazole. Of these isolates, 7.1% (2,763 of 38,835) were resistant to three or more agents and considered multidrug resistant. Among the multidrug-resistant isolates, 97.8% were resistant to ampicillin, 92.8% were resistant to trimethoprim-sulfamethoxazole, 86.6% were resistant to cephalothin, 38.8% were resistant to ciprofloxacin, and 7.7% were resistant to nitrofurantoin. The predominant phenotype among multidrug-resistant isolates (57.9%; 1,600 of 2,793) included resistance to ampicillin, cephalothin, and trimethoprim-sulfamethoxazole. This was the most common phenotype regardless of patient age, gender, or inpatient-outpatient status and in eight of the nine U.S. Bureau of the Census regions. Rates of multidrug resistance were demonstrated to be higher among males (10.4%) than females (6.6%), among patients >65 years of age (8.7%) than patients ≤17 (6.8%) and 18 to 65 (6.1%) years of age, and among inpatients (7.6%) than outpatients (6.9%). Regionally, the rates ranged from 4.3% in the West North Central region to 9.2% in the West South Central region. Given the current prevalence of multidrug resistance among urinary tract isolates of E. coli in the United States (7.1%), continued local, regional, and national surveillance is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
Hooton, T. M., & Stamm, W. E. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70373-1 · Cited by 751
Gupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
Sahm, D. F., Marsilio, M. K., & Piazza, G. (1999) · Clinical Infectious Diseases · doi:10.1086/520195 · Cited by 213
Self-citationZhanel, G. G., Karlowsky, J. A., Harding, G. K. M., Carrie, A., Mazzulli, T., Low, D. E., The Canadian Urinary Isolate Study Group, & Hoban, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1089-1092.2000 · Cited by 190
Self-citationGales, A. C., Jones, R. N., Gordon, K. A., Sader, H. S., Wilke, W. W., Beach, M. L., Pfaller, M. A., Doern, G. V., & SENTRY Study Group Latin America, T. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.295 · Cited by 178
Jones, R. N., Kugler, K. C., Pfaller, M. A., & Winokur, P. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00158-8 · Cited by 151
Gupta, K., Hooton, T. M., Wobbe, C. L., & Stamm, W. E. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00035-7 · Cited by 125
Cited by
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2540-2545.2002 · Cited by 367
Self-citationAsymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy
Schnarr, J., & Smaill, F. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02009.x · Cited by 338
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Metadata
- Authors
- Sahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., & Karlowsky, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2001-05
- Volume
- 45
- Issue
- 5
- Pages
- 1402-1406
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2040452640
- Cited by
- 294
- References
- 8
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.